<VariationArchive VariationID="2579194" VariationName="GRCh38/hg38 2q13(chr2:110123182-110205164)x0" VariationType="copy number loss" Accession="VCV002579194" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-30" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2744232" VariationID="2579194">
      <GeneList>
        <Gene Symbol="LOC126806306" FullName="P300/CBP strongly-dependent group 1 enhancer GRCh37_chr2:110906815-110908014" GeneID="126806306" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110149238" stop="110150437" display_start="110149238" display_stop="110150437" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="NPHP1" FullName="nephrocystin 1" GeneID="4867" HGNC_ID="HGNC:7905" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110123348" stop="110205013" display_start="110123348" display_stop="110205013" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="110880912" stop="110962638" display_start="110880912" display_stop="110962638" Strand="-" />
          </Location>
          <OMIM>607100</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh38/hg38 2q13(chr2:110123182-110205164)x0</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>2q13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="110123182" stop="110205164" display_start="110123182" display_stop="110205164" variantLength="81983" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh38/hg38 2q13(chr2:110123182-110205164)x0 AND Nephronophthisis 1" Accession="RCV003327633" Version="2">
        <ClassifiedConditionList TraitSetID="911">
          <ClassifiedCondition DB="MedGen" ID="C1855681">Nephronophthisis 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-09-16" MostRecentSubmission="2023-09-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31690835</ID>
          <ID Source="pmc">7313390</ID>
          <ID Source="DOI">10.1038/s41436-019-0686-8</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="911" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3445" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nephronophthisis familial juvenile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 1</ElementValue>
                <XRef ID="21201" DB="GeneTests" />
                <XRef ID="Nephronophthisis+1/5141" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009728" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPH1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NPHP1</ElementValue>
                <XRef Type="MIM" ID="256100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18645" />
                <XRef ID="18645" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="93592" DB="Orphanet" />
              <XRef ID="C1855681" DB="MedGen" />
              <XRef ID="MONDO:0009728" DB="MONDO" />
              <XRef Type="MIM" ID="256100" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7549703" SubmissionDate="2023-09-11" DateLastUpdated="2023-09-16" DateCreated="2023-09-16">
        <ClinVarSubmissionID localKey="POL_FAM86|OMIM:256100|copy:0|refcopy:2" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004034283" DateUpdated="2023-09-16" DateCreated="2023-09-16" Type="SCV" Version="1" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
          <Comment>A homozygous deletion of NPHP1 was identified by exome sequencing in two siblings with nephronophthisis ([GRCh 38] chr2:110123182_110205164x0). These breakpoints have been estimated by exome sequencing only and therefore may not reflect the true breakpoints. Inheritance information is unavailable. The patient phenotypes are nonspecific, but are consistent with cases described in the literature and/or published databases with overlapping variants. There is complete overlap with the NPHP1 gene. This alteration is then predicted to lead to an absent protein. Loss of function of NPHP1 is an established disease mechanism in autosomal recessive nephronophthisis (https://search.thegencc.org/). A slightly larger overlapping deletion has been identified in 0.3% (22/7624) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; Structural variant: DEL_2_20944). Although a deletion overlapping the region of this CNV has been seen in the general population in a heterozygous state, its frequency is not high enough to rule out a pathogenic role. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive nephronophthisis. The ACMG/ClinGen evidence codes and points used in this curation are as follows: 1: 0 points, 2: 0.90 points, 4-5: 0.15 points; Total: 1.05 points; Riggs 2020 (PMID: 31690835)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh38" Chr="2" start="110123182" stop="110205164" variantLength="81983" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">0</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="256100" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13816677</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7549703" TraitType="Disease" MappingType="XRef" MappingValue="256100" MappingRef="OMIM">
        <MedGen CUI="C1855681" Name="Nephronophthisis 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

